12/19
09:15 am
tnfa
TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs
High
Report
TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs
12/9
09:00 am
tnfa
TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference
Low
Report
TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference
10/2
09:10 am
tnfa
TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
High
Report
TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market